You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ITIl-168

Showing 1 - 25 of 143
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Cancer, Head and Neck Squamous Cell Carcinoma, NSCLC Trial in Boston, Saint Louis (ITIL-168)

Withdrawn
  • Cervical Cancer
  • +2 more
  • ITIL-168
  • (no location specified)
Dec 16, 2022

Epithelial Ovarian Cancer, NSCLC, Renal Cell Carcinoma Trial in Saint Louis, New York (ITIL-306)

Recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • ITIL-306
  • Saint Louis, Missouri
  • +1 more
Aug 15, 2022

CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTS

Completed
  • Atopic Dermatitis
  • Cosmetic study
  • Rio de Janeiro, Brazil
    CIDP
Mar 13, 2023

Advanced Solid Tumor, RAS Mutation, RAF Mutation Trial in Houston, Irving (ABM-168)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Houston, Texas
  • +1 more
Apr 14, 2023

COVID-19 Pneumonia, Pneumonia Trial in Shenzhen (Jaktinib HCl tablets, Placebo)

Not yet recruiting
  • COVID-19 Pneumonia
  • Pneumonia
  • Jaktinib hydrochloride tablets
  • Placebo
  • Shenzhen, Guangdong, China
    The Third People Hospital of Shenzhen
Jan 26, 2023

Mantle Cell Lymphoma Trial in Hangzhou (LP-168 tablet)

Recruiting
  • Mantle Cell Lymphoma
  • LP-168 tablet
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Jun 24, 2023

Clinical Pharmacology Trial ([14C]LP-168)

Not yet recruiting
  • Clinical Pharmacology
  • (no location specified)
Nov 13, 2023

CLL/SLL, Waldenstrom Macroglobulinemia, Follicular Lymphoma Trial in Cincinnati, Columbus, Salt Lake City (LP-168)

Recruiting
  • CLL/SLL
  • +6 more
  • Cincinnati, Ohio
  • +2 more
May 7, 2022

Joint Pain Trial in Mumbai, Nashik, Panvel (E-PR-01 (Low dose), E-PR-01 (High Dose), Placebo)

Not yet recruiting
  • Joint Pain
  • E-PR-01 (Low dose)
  • +2 more
  • Mumbai, Maharashtra, India
  • +3 more
Apr 24, 2023

Mantle Cell Lymphoma (MCL) Trial in China (LP-168)

Not yet recruiting
  • Mantle Cell Lymphoma (MCL)
  • Hefei, Anhui, China
  • +29 more
Feb 7, 2023

Head and Neck Squamous Cell Carcinoma, Melanoma, Cervical Cancer Trial in United States (RPTR-168)

Terminated
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • RPTR-168
  • Scottsdale, Arizona
  • +3 more
Dec 2, 2022

Agitation, Dementia Trial in Springfield (BXCL501, Matching Placebo)

Recruiting
  • Agitation
  • Dementia
  • Springfield, Massachusetts
    BioXcel Clinical Research Site
Dec 16, 2022

Diabetes Type 2 Trial (RF Vapor Ablation)

Not yet recruiting
  • Diabetes Mellitus Type 2
  • RF Vapor Ablation
  • (no location specified)
May 31, 2023

Multiple Sclerosis, NMO Spectrum Disorder Trial in Hangzhou (LP-168 tablet, LP-168 Placebo tablet)

Recruiting
  • Multiple Sclerosis
  • NMO Spectrum Disorder
  • LP-168 tablet
  • LP-168 Placebo tablet
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital Zhejiang University School of Med
Jun 26, 2022

Ventilator Associated Pneumonia, Bronchopulmonary Dysplasia, Respiratory Disease Trial in Gainesville (Standardized oral Care)

Not yet recruiting
  • Ventilator Associated Pneumonia
  • +2 more
  • Standardized oral Care
  • Gainesville, Florida
    Neonatal intensive care unit at Shands children's hospital at th
Aug 14, 2023

B-cell Lymphoma Trial in Beijing, Guangzhou (LP-168 tablet)

Recruiting
  • B-cell Lymphoma
  • LP-168 tablet
  • Beijing, Beijing, China
  • +2 more
Feb 24, 2022

HIV-1 Infection Trial (MK-8507)

Completed
  • HIV-1 Infection
  • (no location specified)
Jul 22, 2022

Advanced Malignant Solid Tumors Trial (Treatment of MNC-168 enteric-coated capsules as a single oral drug)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Treatment of MNC-168 enteric-coated capsules as a single oral drug
  • (no location specified)
May 31, 2022

Covid19 Trial in Japan, Thailand (K-237 0.3-0.4mg/kg (once daily), Placebo 0.3-0.4mg/kg (once daily))

Active, not recruiting
  • Covid19
  • K-237 0.3-0.4mg/kg (once daily)
  • Placebo 0.3-0.4mg/kg (once daily)
  • Aichi, Japan
  • +54 more
Aug 7, 2022

Frailty Trial in Nassau (Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))

Recruiting
  • Frailty
  • Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
  • Nassau, The Bahamas, Bahamas
    The Partners Clinical Research Centre at The Medical Pavilion
Oct 2, 2023

COVID-19 Pneumonia, Respiratory Parameters Trial (deep breathing and coughing exercises with triflo)

Recruiting
  • COVID-19 Pneumonia
  • Respiratory Disease
  • deep breathing and coughing exercises with triflo
  • Bartın, Turkey
    Bartın University
Oct 8, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.1 GBq (30 mCi) of 177Lu-P17-087, 1.1 GBq (30 mCi) of

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • 1.1 GBq (30 mCi) of 177Lu-P17-087
  • 1.1 GBq (30 mCi) of 177Lu-P17-088
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 30, 2022

Lung Cancer, Surgery Trial in Montreal (Mixed-nutriend supplement (NUT), Multimodal Prehabilitation (MM), Placebo Control

Recruiting
  • Lung Cancer
  • Surgery
  • Mixed-nutriend supplement (NUT)
  • +2 more
  • Montreal, Quebec, Canada
    Research Institute of the McGill University Health Centre
Jul 12, 2023

Rett Syndrome Trial in Worldwide (Sarizotan low dose, Sarizotan high dose, Placebo)

Terminated
Has Results
  • Rett Syndrome
  • Sarizotan low dose
  • +2 more
  • Birmingham, Alabama
  • +13 more
Nov 22, 2021

Advanced Hepatocellular Carcinoma Trial in Chengdu (Lenvatinib combined with TACE and Camrelizumab)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Lenvatinib combined with TACE and Camrelizumab
  • Chengdu, Sichuan, China
    HuaXi hospital
Feb 12, 2023